These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32529817)

  • 41. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
    Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T
    J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodynamic therapy for superficial bladder cancer under local anaesthetic.
    Shackley DC; Briggs C; Gilhooley A; Whitehurst C; O'Flynn KJ; Betts CD; Moore JV; Clarke NW
    BJU Int; 2002 May; 89(7):665-70. PubMed ID: 11966622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interstitial Doppler optical coherence tomography monitors microvascular changes during photodynamic therapy in a Dunning prostate model under varying treatment conditions.
    Standish BA; Jin X; Smolen J; Mariampillai A; Munce NR; Wilson BC; Vitkin IA; Yang VX
    J Biomed Opt; 2007; 12(3):034022. PubMed ID: 17614730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Light delivery device modelling for homogenous irradiation distribution in photodynamic therapy of non-spherical hollow organs.
    Tan Y; Sun S; Chen D; Qiu H; Zeng J; Wang Y; Zhao H; Gu Y
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102320. PubMed ID: 33957275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of patient-specific treatment planning on eligibility for photodynamic therapy of deep tissue abscess cavities: retrospective Monte Carlo simulation study.
    Li Z; Nguyen L; Bass DA; Baran TM
    J Biomed Opt; 2022 Feb; 27(8):. PubMed ID: 35146973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
    Chin W; Lau W; Cheng C; Olivo M
    Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photodynamic therapy with the novel photosensitizer chlorophyllin f induces apoptosis and autophagy in human bladder cancer cells.
    Lihuan D; Jingcun Z; Ning J; Guozeng W; Yiwei C; Wei L; Jing Q; Yuanfang Z; Gang C
    Lasers Surg Med; 2014 Apr; 46(4):319-34. PubMed ID: 24464873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tetrahydroporphyrin-tetratosylat (THPTS): A near-infrared photosensitizer for targeted and efficient photodynamic therapy (PDT) of human bladder carcinoma. An in vitro study.
    Berndt-Paetz M; Weimann A; Sieger N; Schastak S; Riyad YM; Griebel J; Arthanareeswaran VKA; Stolzenburg JU; Neuhaus J
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():244-251. PubMed ID: 28279796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid.
    Xiao Z; Tamimi Y; Brown K; Tulip J; Moore R
    Urol Oncol; 2002; 7(3):125-32. PubMed ID: 12474546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate.
    Berrahmoune S; Fotinos N; Bezdetnaya L; Lange N; Guedenet JC; Guillemin F; D'Hallewin MA
    Photochem Photobiol Sci; 2008 Sep; 7(9):1018-24. PubMed ID: 18754047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).
    Bader MJ; Stepp H; Beyer W; Pongratz T; Sroka R; Kriegmair M; Zaak D; Welschof M; Tilki D; Stief CG; Waidelich R
    Urol Oncol; 2013 Oct; 31(7):1178-83. PubMed ID: 22440147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Photodynamic therapy for glioblastoma: A preliminary approach for practical application of light propagation models.
    Dupont C; Vignion AS; Mordon S; Reyns N; Vermandel M
    Lasers Surg Med; 2018 Jul; 50(5):523-534. PubMed ID: 28906571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monte carlo model of stricture formation in photodynamic therapy of normal pig esophagus.
    Jones LR; Preyer NW; Wolfsen HC; Reynolds DM; Davis MA; Wallace MB
    Photochem Photobiol; 2009; 85(1):341-6. PubMed ID: 19161398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.
    Verigos K; Stripp DC; Mick R; Zhu TC; Whittington R; Smith D; Dimofte A; Finlay J; Busch TM; Tochner ZA; Malkowicz S; Glatstein E; Hahn SM
    J Environ Pathol Toxicol Oncol; 2006; 25(1-2):373-87. PubMed ID: 16566729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Photodynamic therapy of bladder cancer. A new option].
    Neuhaus J; Schastak S; Berndt M; Walther J; Dietel A; Sieger N; Stolzenburg JU
    Urologe A; 2013 Sep; 52(9):1225-32. PubMed ID: 24026059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial).
    Filonenko EV; Kaprin AD; Alekseev BY; Apolikhin OI; Slovokhodov EK; Ivanova-Radkevich VI; Urlova AN
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():106-109. PubMed ID: 27671517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes.
    Chang SC; MacRobert AJ; Bown SG
    J Urol; 1996 May; 155(5):1749-53. PubMed ID: 8627877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry.
    Woodhams JH; Macrobert AJ; Bown SG
    Photochem Photobiol Sci; 2007 Dec; 6(12):1246-56. PubMed ID: 18046479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How tissue optics affect dosimetry of photodynamic therapy.
    Jacques SL
    J Biomed Opt; 2010; 15(5):051608. PubMed ID: 21054082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy Beacons.
    Luby BM; Walsh CD; Zheng G
    Angew Chem Int Ed Engl; 2019 Feb; 58(9):2558-2569. PubMed ID: 29890024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.